Bal Pharma Limited (NSE: BALPHARMA), ISIN INE083D01012 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
BALPHARMA last traded at ₹88.14 (+1.18%), with a 52-week range of ₹59.69 to ₹112.97 (as of 30 Jul 2026).
Shareholding as of Mar 2026: promoters 50.86%, FIIs 0.14%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 64/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.